As a result, it was confirmed that the proliferation of breast cancer cells (MTV/TM-011 or MDA-MB-231) treated with the CM obtained from adipocytes-Grem2 was significantly reduced compared to that of cells treated with CM obtained from adipocytes-mock (Fig. 4a). This evidence concerns the gene GREM2 and breast cancer.